Silodosin: a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia

By Osman Nadir I   Chapple Christopher R   Cruz Francisco   Desgrandchamps François   Llorente Carlos   Montorsi Francesco  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 2085-2096

Informa Healthcare

Access to resources Recommend Favorite

Subtype selective 1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia

By Forray C.   Noble S.A.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2073-2094

Informa Healthcare

Access to resources Recommend Favorite

Silodosin: Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia

By Curran Monique P.  

Drugs, Vol. 71, Iss. 7, 2011-05 ,pp. : 897-907

Adis International

Access to resources Recommend Favorite

-Adrenoceptor Antagonists in the Treatment of Benign Prostatic Hyperplasia

By Cooper K.L.   McKiernan J.M.   Kaplan S.A.  

Drugs, Vol. 57, Iss. 1, 1999-01 ,pp. : 9-17

Adis International

Access to resources Recommend Favorite

Silodosin in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia†: Profile Report

By Curran Monique P.  

Drugs & Aging, Vol. 28, Iss. 10, 2011-10 ,pp. : 843-845

Adis International

Access to resources Recommend Favorite